BRENCO Transcripts | United States | Greenbook

BRENCO Transcripts

At BRENCO Transcripts we make it our business to understand your business language and capture in-depth analytical discussions.

Why choose Us

What is BRENCO Transcripts?

Since 2002, BRENCO Transcripts has provided unsurpassed transcription service to numerous industry leaders in the market research, health-care/pharmaceutical, and information technology communities. We are accountable for meeting every deadline and have one of the highest accuracy rates in the trade. Our dedicated team initiates extensive topic research utilizing various industry publications and the Web. With our broad knowledge base and excellence in service, we have earned one of the best reputations in the transcription service industry.
Not only do we work hard on your transcripts; we work hard on developing longstanding business relations. We look forward to the opportunity of being your first and only choice transcription company.

BRENCO Transcripts Recognition & Certifications

Women-Owned Business

BRENCO Transcripts Services and Expertise

Explore market research solutions, industries, markets, and business issues covered by BRENCO Transcripts

Industries / Sectors Serviced and Demographics Studied

INFO

Contact

Narragansett, RI

United States

Mailing address
1499 Ocean Rd.

148

Narragansett, RI,
United States
02882

Key personnel

Brenda Longstreth-Cabral
Owner & Founder
(401) 378-8544 378-8544)

Market Research FAQs with Expert Insights

Greenbook experts provide answers to a wide range of questions, both common and uncommon, about market research and analytics that connect to the kinds of services and expertise BRENCO Transcripts offers.

When are projective techniques the best choice in research decisions?

How can pharma research better capture patient experiences outside clinical?

How do I forecast prescribing behavior based on physician awareness?

How can we harmonize enterprise buyer research across global regions?

Can AI tools improve forecasting for new drug launches?